Title | Description |
|---|---|
| Trial ID | KF8001-01 |
| Compound | GRT8001, Adorlan®, Adorlan Forte® |
| Trials sponsor | Grünenthal S.A. |
| Trial phase | 3 |
| Brief title | Moderate to severe acute pain after third molar extraction |
| Indication | Pain after third molar extraction |
| UTN | U1111-1179-2333 |
| CTG ID | NCT03714672 |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | August 26, 2017 |
| LPO | March 22, 2018 |
| Countries | Germany, United States |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | |
| Documents | kf8001-01-lay-summary-english kf8001-01-lay-summary-spanish kf8001-01-expert-summary |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.